High Throughput Sequencing Detect Gingivitis and Periodontal Oral Bacteria in Alzheimer’s Disease Autopsy Brains by Siddiqui, Huma et al.
Article
High Throughput Sequencing Detect Gingivitis and 
Periodontal Oral Bacteria in Alzheimer’s Disease 
Autopsy Brains
Siddiqui, Huma, Eribe, Emenike R. K., Singhrao, Simarjit Kaur and 
Olsen, Ingar
Available at http://clok.uclan.ac.uk/29686/
Siddiqui, Huma, Eribe, Emenike R. K., Singhrao, Simarjit Kaur ORCID: 0000­0001­9573­5963 
and Olsen, Ingar (2019) High Throughput Sequencing Detect Gingivitis and Periodontal Oral 
Bacteria in Alzheimer’s Disease Autopsy Brains. Journal of Neuroscience Research, 1 (1) (3). 
ISSN 0360­4012  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
Research Article 2019; 1(1): 3 NEURO RESEARCH
1
Citation: Singhrao SK (2019). High Throughput Sequencing Detect Gingivitis and Periodontal Oral Bacteria in Alzheimer’s Disease 
Autopsy Brains. Neuro Research 1(1): 3.
High Throughput Sequencing Detect Gingivitis and 
Periodontal Oral Bacteria in Alzheimer’s Disease Autopsy 
Brains
Huma Siddiqui1, Emenike RK Eribe1, Sim K Singhrao2* and Ingar Olsen1
¹Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway 
2Dementia & Neurodegenerative Diseases Research Group, Faculty of Clinical and Biomedical Sciences, School 
of Dentistry, University of Central Lancashire, Preston, United Kingdom
*Corresponding author: 
Sim K Singhrao
Dementia & Neurodegenerative Diseases Research 
Group, Faculty of Clinical and Biomedical Sciences, 
School of Dentistry, University of Central Lancashire, 
Preston, United Kingdom.
Received : August 17, 2019 
Published : September 10, 2019
ABSTRACT
The sporadic form of Alzheimer’s disease (AD) is the most 
common form of dementia characterized microscopically 
by the presence of amyloid-beta (Aβ) plaques and tau-
neurofibrillary tangles with clinical presentation of cognitive 
deficit. Its etiology remains obscure. The cited literature from 
epidemiological studies suggests the presence of gingivitis 
and periodontitis almost double the risk for AD over a 10-year 
period. This feasibility study used 16S rDNA high throughput 
sequencing to evaluate the bacterial components of the oral 
microbiome in snap frozen human AD and non-AD control 
brains. Specimens (n=20), 10 from AD brains and 10 from 
non-AD age-matched brains were subjected to molecular 
barcoding “blindly” with high throughput sequencing. Initial 
PCR treatment, using 14 different primer sets separately 
and in combination, identified 4 (40%) positive samples in 
the AD-group and 6 (60%) positive samples in the non-AD-
group with bacterial species associated with the oral and the 
gastrointestinal tract. Brain cell lysates were validated for the 
presence of bacterial peptidoglycan and showed 8 out of 10 
brains to be positive for this universal bacterial protein in both 
the AD and non-AD groups. Actinomycetales and Prevotella 
(bacterial marker for gingivitis) and Treponema and Veillonella, 
(periodontitis) were present exclusively in the AD group. 
This study confirmed Actinomycetales and Bacteroidales 
(Treponema and Veillonella species) were exclusively isolated 
from AD brain tissue, and supports other epidemiological 
which demonstrate gingivitis and periodontal disease to be 
associated with AD. 
KEYWORDS: Alzheimer’s Disease; Human Brains; High 
Throughput Sequencing; 16S rDNA; Bacteria; Oral; Intestinal.
INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative disease and 
represents the most common form of dementia. Its prevalence 
is still rising worldwide [1]. Atrophy and neuronal death in the 
frontotemporal region including the hippocampus, containing 
amyloid-beta plaques and neurofibrillary tangles, together 
with a clinical history of dementia confirm presence of AD. The 
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clear majority suffers from the sporadic form of AD (95% of 
the cases) [2] in which interplay between both susceptibility 
genes and environmental factors is implicated [3]. One of 
the greatest risk factors for developing AD is advancing age, 
which also encompasses an aging immune system that has 
the potential to facilitate dysbiosis of host microbiomes. 
The apolipoprotein APOE ε4 polymorphic isoform is common 
to all forms of AD [4]. Patients carrying the ApoE4 gene 
suffer from hyperlipidaemia and this predisposes them to 
atherosclerosis [5], bacterial infections [6,7] and the ensuing 
inflammation [7,8]. The ApoE4 susceptibility gene acts 
in combination with environmental risk factors to cause 
pathology. These concepts have given rise to the importance of 
identifying modifiable risk factors together with management 
of these risk factors in order to either delay or prevent the onset 
of dementia. For example, dysbiotic oral and gastrointestinal 
tract host microbiome(s) represent a potential environmental 
risk factor. Pathogens may spread from their primary niche to 
the brain, encouraging AD development [2, 9,10]. In addition, 
epidemiological studies identified a 10 year exposure to both 
gingivitis and periodontal disease promoted AD pathogenesis 
[11,12]. Furthermore, a prospective laboratory-based study 
demonstrated the directionality and the timeline of periodontal 
disease being a risk for AD by showing circulating antibodies 
to Fusobacterium nucleatum and Prevotella intermedia (oral 
bacteria) to be associated to a cognitive deficit 10 years later 
[13]. Notably S, et al. [14] showed tooth loss due to periodontal 
disease can almost double the risk for AD onset. 
The evidence supporting that inheritance of the ApoE4 
allele being an inflammatory phenotype is demonstrated 
experimentally via an increased secretion of inflammatory 
cytokines [8] and an excessively activated complement cascade 
[15,16]. Inflammatory mediators increase the permeability of 
the blood-brain barrier (BBB) to circulating pathogens, serum 
proteins and cytokines in the systemic circulation, providing 
an opportunity for the influx of dysbiotic bacteria into the 
brain [8,17-19]. This is illustrated by the susceptibility of the 
ApoE4 carriers to Chlamydia pneumoniae and herpes simplex 
virus (HSV) type 1 infections in AD brains [20-22]. Furthermore, 
those individuals having inherited the ApoE4 polymorphic 
gene [23] demonstrate Chlamydia-associated infections are 
able to reach the brain via infected monocytes following 
increased BBB permeability [24]. For a more focused review on 
this subject see ref [25]. 
Although a polymicrobial component is an essential 
contributor to periodontal pathogenesis, this does not 
completely exclude other non-microbial related factor(s) such 
as lifestyle behaviours (poor oral hygiene, smoking, excessive 
drinking, stress) and host’s immune responses. A variety of 
microorganisms including C. pneumoniae [23], HSV type 1 
[26] and periodontal pathogens, particularly Porphyromonas 
gingivalis (previously Bacteroides) and Treponema species 
have been detected in AD brains [27-30], but their relevance 
to the pathogenesis of this neurodegenerative disease, 
is debated. However, due to the recent in vivo findings 
of oral infections of rodents with P. gingivalis [17], and its 
association with Actinobacteria in AD brains argues at least 
some relevance for the pathogenesis of AD in the context of 
bacterial infections. 
Currently there is only one published report that analysed the 
bacterial component of the host’s microbiome in frozen and 
fixed post-mortem tissue from AD and control cases [31]. This 
initial study [31] used the 16S rDNA approach for its sensitivity 
and suitability to analyze bacterial DNA in frozen and fixed 
brain tissue. 
The current study used high throughput sequencing 
and molecular barcoding to investigate the presence of 
bacterial genera in the same cohort of AD brain tissues 
that were examined in a previous study using biochemical 
and immunofluorescence methodology that detected 
lipopolysaccharide (LPS) as a signature of P. gingivalis in AD 
but not control cases [9]. 
MATERIALS AND METHODS
Bacterial DNA evaluation
Brain tissue samples: The human brain tissue used in this 
study was obtained from the Brains for Dementia Research 
(BDR) network and was kindly provided by the Newcastle 
Brain Tissue Resource in 2010 for a PhD project [9,32]. A new 
request was approved by the BDR for re-use of surplus human 
brain tissue samples for this study. All research procedures 
met approval of our academic institute (University of Central 
Lancashire, Ref. No. 343) and the ethical guidelines, including 
adherence to the legal requirements of the study in the UK. 
The study also received regional approval from the Norwegian 
REC (Regional Committee for Medical and Health Research 
Ethics, Southeast, Ref. No. 20152386). 
The specimens were obtained from neuropathologically 
confirmed AD (n=10) patients comprising of eight females 
and two male donors with average age (79 and 83 years) 
respectively (Table 1). Where possible, age-matched non-AD 
2019; 1(1): 3Singhrao SK, et al. 
Citation: Singhrao SK (2019). High Throughput Sequencing Detect Gingivitis and Periodontal Oral Bacteria in Alzheimer’s Disease 
Autopsy Brains. Neuro Research 1(1): 3. 3
control (n=10) brains, seven females and three males with 
average age (84 and 73 years respectively) were used. Samples 
of frozen human brain tissue were taken from an area of the 
brain adjacent to the lateral ventricle of the parietal lobe. 
On receipt, all specimens were allocated a code number and 
thereafter all data recorded from those cases were identified 
by that code. The cases are identified here as AD and non-
AD controls for clarity of reporting. Related information 
(age, gender, cause of death, APOE allelic form, post-mortem 
and storage interval, number of bacteria detected by high 
throughput sequencing compared with the laboratory PCR 
methodology) for each anonymized case is given in Table 1. 
The remaining tissue samples (approximating to 50 mg of tissue 
for each brain) were dissected, and genomic DNA isolation 
was performed in a regularly serviced PCR hood as expected 
per forensic DNA testing procedures. Brain specimens were 
thawed out in a PCR hood, and the remaining snap-frozen 
unfixed tissue was subjected to genomic DNA isolation at 
Table 1: The age, post-mortem interval/cause of death, storage interval, and cases in which bacterial DNA detected in the cases analysed.
Case Age and sex
Post-mortem 
interval (hours)
Cause of death and APOE 
allelic form (in bold text)
Storage interval 
in years
Bacterial numbers detect-
ed by high throughput 
sequencing
Bacterial DNA detect-
ed by lab PCR
AD 1 78/F 12 Unknown/unknown 21 0 Yes
AD 2 77/F 8 Unknown/unknown 19 19421 Yes 
AD 3* 84/F 8
1a heart failure due to 1b senile 
dementia. 3/4
19 1266 No
AD 4 84/F 8 Likely bronchopneumonia. 3/3 19 0 No 
AD 5* 85/F 9 Unknown. 3/3 18 0 No 
AD 6 83/M 9 Unknown. 4/4 17 0 No 
AD 7 80/F 4 Pulmonary embolism. 4/4 17 0 Yes
AD 8* 83/F 10 Unknown/unknown 16 2573 Yes 
AD 9 63/F 11 Bronchopneumonia. 3/4 9 0 Yes 
AD 10* 83/M 12 Unknown. 2/2 5 5374 Yes 
Non-AD 1 69/F 16 Gastric cancer. 3/3 9 503 Yes
Non-AD 2 72/M 17
Esophageal adenocarcinoma. 
3/4
9 0 Yes
Non-AD 3 103/F 21 Pneumonia. 3/3 9 40045 No
Non-AD 4 78/F 23
Metastatic esophageal carcino-
ma with broncho-esophageal 
fistula. 2/3
8 2726 No 
Non-AD 5 89/F 24
Heart failure 1a heart failure 1b 
mixed aortic valve. 3/3
8 0 No
Non-AD 6 67/M 43
Metastatic laryngeal carcinoma 
(non-occupational)/unknown
4 0 No 
Non-AD 7 81/M 34
1a pneumonia 1b: infective 
endocarditis. 2/3
3 1670 No
Non-AD 8 88/F 34
1a aspiration pneumonia, 1b 
RT total anterior circulation 
stroke. 3/3
4 7795 No 
Non-AD 9 78/F 22
Metastatic cancer, primary 
origin unknown (probably 
ovarian). 2/3
3 0 No 
Non-AD 
10
89/F 22
Ischemic bowel and multi-organ 
failure. 3/3 
3 3328 No
Total bacteria after all filtration = 84.701; * Cases positive for P. gingivalis LPS [9]
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the University of Central Lancashire as described below. Each 
specimen was placed into a sterile labelled Eppendorf® tube 
containing 180 µl enzymatic buffer (20 mM Tris-Cl, pH 8.0, 2 
mM sodium EDTA, and 1.2% triton x-100) to which lysozyme 
(Sigma-Aldrich Poole, Dorset, UK) was added (20 mg/ml). All 
lids were closed and then covered with Parafilm® M (Sigma-
Aldrich). Following an overnight incubation at 37ºC with 
shaking, fresh 180 µl of buffer with 20 µl proteinase K (Sigma-
Aldrich) were added to each tube and the content was mixed 
and re-incubated overnight at 56ºC as before. Next day, the 
tubes from the incubator were removed and an equal volume 
of phenol/chloroform/isoamyl alcohol (25:24:1) from Sigma-
Aldrich was added to the digested sample and vortex-mixed. 
The tubes were centrifuged at room temperature for 5 min at 
21,000 RCF. The upper aqueous phase was collected into a pre-
labelled sterile, Eppendorf® tube. A cocktail (glycogen, Sigma-
Aldrich, 20 µg/µl, 7.5 M ammonium acetate (Sigma-Aldrich) 
at pH 5.2 (0.5 × volume of sample) and 100% ethanol, 2.5 × 
volume of sample) were added, reagent by reagent, into the 
aqueous phase. The tubes were placed at -20ºC overnight to 
precipitate DNA. Following precipitation, the tubes containing 
each sample were centrifuged at 4ºC for 30 min at 21,000 RCF 
to pellet the genomic DNA. The pellets were washed three 
times in 150 µl 70% ice cool ethanol and centrifuged twice 
at 4ºC for 2 min at 21,000 RCF. The isolated genomic DNA (in 
ethanol) was sent to the University of Oslo, Oslo, Norway via 
an overnight courier service. All specimens were coded to 
ensure the experimenter remained completely unaware of 
which cases corresponded to AD and non-AD control brains.
PCR and high throughput sequencing
At the University of Oslo, DNA samples (n=20) were 
suspended in 100 µl Qiagen buffer (Qiagen Instruments AG, 
Stockach, Germany) and subjected to PCR using 14 different 
primer sets (Eurofins Genomics, Ebersberg, Germany) 
(Table 2). Combinations of forward and reverse primers 
targeting the V4 region were used: 502F/701R, 503F/701R, 
501F/702R, 503F/702R, 504F/702R, 507F/702F, 508F/702R, 
503F/703R, 504R/703R, and 507F/703R [33]. The v3F. forsyth 
primer was combined with 701R-708R. PCR reactions were 
performed (in triplicate) for each sample. Each 20 μl volume 
of PCR reaction contained the following (1 μl of 10 pool/μl 
forward and reverse primers, 2 μl of template DNA and 16 μl 
AccuPrime™ Pfx SuperMix mixture (Thermo Fisher Scientific, 
Wilmington, DE) consisting of 22 U/ml Thermococcus species 
KOD thermostable polymerase complexed with anti-KOD 
antibodies (Invitrogen, Carlsbad, CA), 66 mM Tris-SO4 (pH 
8.4), 30.8 mM (NH4)2SO4, 11 mM KCl, 1.1 mM MgSO4, 330 µM 
dNTPs, AccuPrime™ proteins, and stabilizers purchased from 
Invitrogen). Prior to PCR, pipettes, tips and Eppendorf® tubes 
were decontaminated under UV irradiation for 30 min in the 
PCR assembling hood. PCR amplifications were performed on 
a GeneAmp PCR System 2700 instrument (Applied Biosystems) 
using sterile reagents with initial denaturation at 95ºC for 5 
min followed by 30 cycles of denaturation at 95ºC for 20 sec, 
annealing at 55ºC for 30 sec, extension at 72ºC for 60 sec, with 
a final extension at 72ºC for 10 min. The product was stored 
at 4ºC. Replicate amplicons were pooled and visualized on 
1.0 % Seakam agarose gels using 10 μl GelRed Nucleic acid 
binding dye (Biotium Inc., Fremont, CA) in 1 × TBE buffer. The 
amplicons were cleaned using a SequalPrepTM Normalization 
Plate (96) kit (Invitrogen) according to the manufacturer’s 
instructions. Molecular identifier (MID) tags, 10-mer, were used 
as sample identifiers (Table 2). All pooled PCR products were 
purified using the Agencourt AMPure PCR purification system 
(Beckman Coulter, Brea, CA). The recovered DNA quantity was 
recorded (Nanodrop 3300 Flurospectrometer, Thermo Fisher 
Scientific).
High throughput sequencing was performed using the 
Illumina MiSeq 500-cycle v2 (2 × 250 bp) kit (Illumina, 
San Diego, CA), which resulted in 15 GB, 25 M SE/50M PE 
raw reads. Sequencing was performed at the Department 
of Biochemistry, DNA Sequencing Facility, University of 
Cambridge, UK (http://www.bioc.cam.ac.uk/dnasequencing). 
Processing of the sequencing data and taxonomy assignment 
were accomplished with an algorithm modified and based 
on that described by Siddiqui et al., [34]. To maximize the 
assignment rate, raw reads were used directly without quality 
filtering. Reads were first assigned with sample IDs based 
on the MID sequences and then BLASTN-searched against 
a combined set of 16S rRNA reference sequences consisting 
of the HOMDEXTGG set published by Siddiqui et al., [34] and 
the NCBI 16S rRNA reference sequence set (ftp://ftp.ncbi.nim.
nih.gov/blast/db/16SMicrobial.tar.gz). These combined, well 
curated and near full-length reference sequences represented 
1,151 oral and 12,013 non-oral microbial species.
Statistical analyses 
To analyze any significant differences between the microbiota 
of AD and control brains a statistical method introduced in 
Metastats (www.metastats.cbcb.umd.edu) was used. This 
method employs a false discovery rate to improve specificity 
in high complexity environments, and in addition handles 
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sparsely sampled features using Fisher’s exact test [35]. The 
Shapiro-Wilk test was used for assessing differences in the 
post-mortem interval and the non-parametric Mann-Whitney 
U test for independent samples with IMB SPSS statistical 
package version 23. A p-value of ≦ 0.05 was considered 
significant.
Table 2: PCR primers used in this study.
No. Oligo name Sequence
1 V4.SA501
5’-AATGATACGGCGACCACCGAGATCTACACATCGTACGTATG-
GTAATTGTGTGCCAGCMGCCGCGGTAA -3’
2 V4.SA502
5’-AATGATACGGCGACCACCGAGATCTACACACTATCTGTATG-
GTAATTGTGTGCCAGCMGCCGCGGTAA -3’
V4.SA503
5’-AATGATACGGCGACCACCGAGATCTACACTAGCGAGTTAT-
GGTAATTGTGTGCCAGCMGCCGCGGTAA-3’
3 V4.SA504
5’-AATGATACGGCGACCACCGAGATCTACACCTGCGTGTTATG-
GTAATTGTGTGCCAGCMGCCGCGGTAA-3’
4 V4.SA507
5’-AATGATACGGCGACCACCGAGATCTACACGGATATCTTATG-
GTAATTGTGTGCCAGCMGCCGCGGTAA -3’
5 V4.SA508
5’-AATGATACGGCGACCACCGAGATCTACACGACACCGTTAT-
GGTAATTGTGTGCCAGCMGCCGCGGTAA -3’
6 V4.SA701
5’-CAAGCAGAAGACGGCATACGAGATAACTCTCGAGTCAGT-
CAGCCGGACTACHVGGGTWTCTAAT -3’
7 V4.SA702
5’-CAAGCAGAAGACGGCATACGAGATACTATGTCAGTCAGT-
CAGCCGGACTACHVGGGTWTCTAAT-3’
8 V4.SA703
5’-CAAGCAGAAGACGGCATACGAGATAGTAGCGTAGTCAGT-
CAGCCGGACTACHVGGGTWTCTAAT-3’
9 V4.SA704
5’-CAAGCAGAAGACGGCATACGAGATCAGTGAGTAGTCAGT-
CAGCCGGACTACHVGGGTWTCTAAT-3’
10 V4.SA705
5’-CAAGCAGAAGACGGCATACGAGATCGTACTCAAGTCAGT-
CAGCCGGACTACHVGGGTW TCTAAT-3’
11 V4.SA706
5’-CAAGCAGAAGACGGCATACGAGATCTACGCAGAGTCAG-
wTCAGCCGGACTACHVGGGTWTCTAAT-3’
12 V4.SA707
5’-CAAGCAGAAGACGGCATACGAGATGGAGACTAAGTCAGT-
CAGCCGGACTACHVGGGTWTCTAAT-3’
13 V4.SA708
5’-CAAGCAGAAGACGGCATACGAGATGTCGCTCGAGTCAGT-
CAGCCGG ACTACHVGGGTWTCTAAT-3’
14 V3F.forsyth
5’-AATGATACGGCGACCACCGAGATCTACACTATGGTA-
ATTGTCCTACGGGAGGCAGCAG -3’
Bacterial peptidoglycan protein validation
Tissue lysates of all AD and non-AD brains: At the University 
of Central Lancashire, UK, tissue lysates were prepared from 
all human brains as previously reported [9] and were used 
for dot blots with the anti-bacterial peptidoglycan antibody 
(MAB995) for overall presence of bacteria in the specimens.
Dot blot: To confirm the presence of bacterial peptidoglycan, 
dot blots were performed by transferring 30 µg of total 
protein onto a polyvinylidene difluoride membrane (PVDF, 
Immobilon-P, Millipore, UK), which had been previously 
permeabilized with methanol and hydrated in 1 × transfer 
buffer (diluted from 10 × stock transfer buffer: 144 g glycine, 
30 g Tris base/L of distilled water, pH 8.3) in distilled water 
containing 10 % methanol. The membrane was subsequently 
blocked for 30 min at room temperature in 5% w/v skimmed 
milk/PBS then incubated overnight at 4°C with the anti-
bacterial peptidoglycan antibody (MAB 995 from Millipore, UK) 
diluted 1/500 in 5% w/v skimmed milk/PBS. Following 3 × 15 
min washings in PBS containing 0.2% tween 20, the membrane 
was incubated in horse radish peroxidase (HRP)-conjugated 
goat anti-mouse Ig secondary antibody (Chemicon, Millipore, 
UK) diluted 1/10,000 in 5 % w/v skimmed milk/PBS for 2 hrs 
at room temperature. Following further washes in PBS/tween 
20, (as above, 3 × 15 min each) spots were detected using the 
enhanced chemiluminescence detection reagent. Specific 
protein signal from the membranes was visualized using a 
ChemicDoc® (Bio-Rad, UK) and images captured with Image 
Lab® Software Version 3.0.1.
RESULTS
PCR and high throughput sequencing of brain samples
Ten out of 20 samples gave PCR products. The remaining 10 
samples failed even after using a set of 14 primers in different 
combinations. Breaking the code showed that six (60%) of the 
positive samples were from non-AD participants, while four 
(40%) belonged to AD patients. A wide spectrum of bacteria 
was detected in samples from both groups, containing both 
oral and gastrointestinal tract (GI) microbiome species. The 
post-mortem delay for the AD specimens on average was 9 h. 
However, the storage interval from donation of brains to BDR 
and isolating DNA, for this study, on average, overall was 16 
years. For the cases that were significantly associated with the 
presence of bacteria in AD, the average storage interval was 
15 years (Table 1). The AD brain specimens without presence 
of bacteria were of slightly longer storage interval (17 years 
on average). The control, non-AD cases, on average had a 
longer post-mortem delay interval of 26 h compared with 
the AD cases with bacteria present. The storage interval with 
and without bacterial counts for the control, non-AD cases, 
on average, was 6 years. Whilst the cause of death for the AD 
cases with bacteria were unknown for 3 out of 4, one case 
resulted from heart failure (Table 1). For the control group, the 
cause of death was clearly defined (Table 1) whereby 3 out of 
6 cases with bacterial counts had suffered from pneumonia, 
stroke and bacterial sepsis (multiple organ failure). Therefore, 
a significant difference between the AD and non-AD groups 
lies in the post-mortem interval and storage interval.
The distribution of bacterial taxa was sorted into two groups 
comprising of AD and non-AD (not shown). In the AD group 
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the phylum Firmicutes was considerably higher, and the 
Proteobacteria phylum was much lower than in the non-
AD group. The distribution of bacterial families was also 
determined and the dominating family in the AD group was 
Pseudomonadaceae. Figure 1 shows the relative amounts 
of a great number of genera discovered in both groups (see 
Table 1 for actual numbers of bacteria). It was noteworthy 
that members of the Actinomycetales order and Prevotella 
species (typically of Gingivitis) and Treponema and Veillonella 
species (periodontitis) were present in the AD group, but not 
in the non-AD group. Conversely, the genus Fusobacterium 
was seen in the non-AD group, but not in the AD group.
Figure 1: Bacterial reads compiled for the number of genera detected in non-
AD (n=10) and AD (n=10) brains. The Y-axis represents relative percentage (%) 
abundance of bacterial genera.
Statistics for post-mortem delay and storage interval
The Shapiro-Wilk T-test for independent samples showed that 
the post-mortem interval was normally distributed, but that 
storage interval was not. Therefore, the non-parametric Mann-
Whitney U test was used for independent samples for storage 
interval. In both cases the difference was highly significant 
(p-value=0001). Post-mortem interval mean: Shapiro-Wilk, 
T-test (independent samples) for AD=9 hrs and for the non-
AD=26 hrs (p-value=0.0001). For storage interval mean: Mann-
Whitney U test (independent samples) for AD=16 years and 
non-AD 6 years (p-value=0.0001).
Bacterial peptidoglycan dot blot for all brains
Dot blot analysis from tissue lysates from all the brains tested, 
confirmed the presence of the bacterial peptidoglycan protein. 
The positive control bacterial cell lysate from P. gingivalis 
(P.g.) was positive, and the sterile medium (Med) containing 
proteins used as a negative control remained negative for 
both groups of dot blots. Whilst non-AD brain lysates from 
case 2 and case 4 were negative, the non-AD (cases 1, 3, 5, 
6, 7, 8, 9, 10) demonstrated unequivocal density around the 
specimen spots albeit with weaker density around each of the 
specimen spots. The AD brain lysates from the AD case 1 and 
AD case 10 brain lysates were negative whilst only a weaker 
spot appeared in AD brain lysate case 9 compared with AD 
(cases 2, 3, 4, 5, 6, 7, 8). The AD cases 6 and 7 brain lysates 
demonstrated a significantly greater density of the specimen 
dot spots (Figure 2).
Figure 2: Dot blot using lysates from non-AD (n=10) and AD (n=10) brains, bottled 
with mouse anti-bacterial peptidoglycan (MAB 995). The first dot in both blots 
represents lysate from P. gingivalis (P.g.) as a positive control for Gram-negative 
bacteria and the med refers to sterile medium used to culture (P.g.) as a source 
of irrelevant protein as negative control. Non-AD 1-10 are control brains showing 
some bacterial peptidoglycan. The AD 1-10 brain lysates when dot blotted 
demonstrated a significantly greater density in AD 6 suggesting a Gram positive 
bacterial contribution, whilst AD 3, 5, 8 and 10 that were positive for P. gingivalis LPS 
[28] were weak in their dot blot density.
DISCUSSION
Investigating microbial infections in the context of AD brains 
have a negative connotation because of the potential for 
cross-contamination of the brain tissue obtained at post-
mortem with organisms from bowel or systemic tissue. 
Even if compelling evidence indicates a specific pathogen 
to contribute to the pathogenesis of AD, it is unlikely that 
a single “infectious” agent is the exclusive cause of this 
neurodegenerative disease.
It is noteworthy that individuals with the APOE ε4 gene 
are vulnerable to greater amounts of Aβ, oxidative stress, 
lysosomal leakage, infections and pathogen/Aβ driven 
inflammation. These host stressors appear to have little effect 
on the survival of Actinomycetales, perhaps because of their 
association with multispecies of bacteria, which together (as a 
biofilm) tolerate adverse conditions [36]. 
With regards to post-mortem delay, this study demonstrated a 
significant difference in post-mortem delay in controls (26 hrs) 
compared with AD cases (9 hrs). However, the storage interval 
at -80ºC was much shorter than for control cases (6 years) 
compared with AD cases (16 years). 
Within the Cohort, age range at death, and gender were 
similar, however, we cannot rule out whether or not the 
duration of tissue storage (16 years) had added to potential 
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cross-contaminations in the AD cases, despite our results 
showing a minimal effect. Thus, the issue is more likely to be 
related to post-mortem interval and DNA degradation rather 
than cross-contamination.
Appreciation of the use of high throughput sequencing 
methodology is important in view of its likely future application 
in “the diagnostic standard worldwide”. It enables earlier 
discovery of novel infectious agents that may be involved in 
the development of complex diseases with unknown causes, 
which are currently difficult to detect using conventional 
procedures. In addition, the DNA from stored tissue can be 
examined retrospectively if the problem associated with 
degradation of DNA can be overcome.  
In this study, electrophoresis of the PCR products 
demonstrated ten brain tissue specimens to show positive 
amplicons, while the remaining ten were negative. Six 
of the 10 positive PCR specimens belonged to non-AD 
participants, while the other four were from AD brains. 
This outcome does not necessarily mean that individual 
brains were free of bacteria, because DNA is known, under 
post-mortem conditions, to degrade rapidly. From this 
investigation, it appears that a time scale of post-mortem 
delay (9-26 hrs), and the storage interval at -80ºC (16-6 
years) would require further refinements. 
However, using 16S rDNA high throughput sequencing, 
this study detected a wide range of different bacterial 
taxa belonging to the phylogenetic groups Bacteroidetes 
(Treponema, Prevotella) and Actinomycetes, exclusively in 
tissue from four AD (Cases 2, 3, 8, 10) (Table 1). Sequencing 
analysis confirmed Actinomycetes exclusively in AD tissue 
compared with normal brains [31], and P. gingivalis LPS was 
identified in AD (Cases 3, 5, 8 and 10). Surprisingly AD case 6 
(which demonstrated the most prominent dot blot signal) did 
not reveal bacterial DNA using the 16S rDNA high throughput 
sequencing or [32] using PCR methodology, suggesting that 
bacterial LPS may degrade more slowly than DNA.
Dot blot analysis for the bacterial peptidoglycan demonstrated 
bacteria to be present in at least eight brains in both (AD and 
non-AD) groups without significant difference. P. gingivalis 
LPS and the anti-peptidoglycan antibody did not recognize 
this bacterial outer membrane component, however, AD case 
10 (Table 1) but, not case 1, provided evidence for bacterial 
content following PCR [9,32]. It is possible that P. gingivalis 
LPS from the outer membrane vesicles may have bound 
to other species of bacteria, particularly Actinomycetes; as 
demonstrated in AD cases 3 and 10 (Table1) [9,37]. In support 
of this finding, Actinobacteria are commonly found in the 
oral cavity and in the dysbiotic gastrointestinal microbiota 
of AD patients [10]. P. gingivalis outer membrane vesicles 
are known to assemble with Actinomyces viscosus cells [38]. 
Furthermore, the gene coding for a 40 kDa protein in the outer 
membrane vesicle protein of P. gingivalis has previously been 
cloned [39] and was confirmed as an important aggregation 
factor between P. gingivalis and A. viscosus [40]. The increased 
antibody levels to F. nucleatum and P. intermedia have been 
detected in AD patients [13] indicating the relevance of 
bacterial gingivitis/periodontitis and Actinobacteria in this 
study. 
Understanding the AD microbiome is important, although 
this study shows P. gingivalis DNA was not recovered from 
either AD cases or from non-AD-cases. One explanation is 
the scarcity of P. gingivalis DNA in the brain samples, as this 
bacterium is found in low copy numbers, even in its primary 
oral niche (periodontal pocket), where it is a keystone 
bacterium of tissue destruction [41,42]. In addition, due to 
the poor quality of DNA extracted from end-stage AD brains 
at post-mortem, DNA from P. gingivalis may not have been 
amplified. Although not all bacteria were affected, P. gingivalis 
may be an exception in sensitivity to PCR inhibitors and 
other reagents that are used during nucleic acid extraction 
or copuriWed components from the biological sample such 
as bile salts, urea, haeme, heparin, and immunoglobulin Ig 
[43,44]. This limitation was identified and addressed in a 
former study; here the same tissue specimens were analyzed 
with biochemical and immunofluorescence methodology, 
detecting LPS as a signature of P. gingivalis in AD but not control 
cases (4/10) [9]. In this study, oral and intestinal bacterial DNA 
were also identified in the brain tissue from both AD and non-
AD subjects using DNA and high throughput sequencing 
methodology. 
CONCLUSION
In conclusion, the high throughput sequencing methodology 
is likely to be integrated into medical diagnostics worldwide 
and therefore there is a need to test its application for stored 
brain tissues. Our study demonstrated its applicability is 
plausible. It remains unclear whether or not bacteria within 
the post-mortem AD brain are related to systemic bacteria 
associated with the causes of death in AD cases, or to 
changes in bacterial populations following death. This study, 
nevertheless, confirms the presence and identification of 
bacterial species associated with gingivitis and periodontal 
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disease in the AD brains, supporting former (prospective 
and retrospective) laboratory based and epidemiological 
studies. Furthermore, this study highlights Actinobacteria 
possibly binding with P. gingivalis LPS and this has relevance 
for AD pathophysiology. We do not suggest that oral bacteria 
(gingivitis and/or periodontitis pathogens) are responsible for 
all AD cases, but poor oral hygiene, which promotes bacterial 
related periodontal disease, may be a modifiable risk for AD in 
some individuals.  
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